文献速递肾血管病与高血压慢性肾脏病

肾脏去神经术:现状及对肾内科医生的意义

Renal denervation: where do we stand and what is the relevance to the nephrologist?
PubMed 文献 · Nephrol Dial Transplant · 2022-01-01

本综述基于近期假手术对照试验显示导管肾脏去神经术可显著降低血压且耐受性和安全性良好,从肾内科视角讨论肾脏与神经激素激活在高血压中的作用及去神经术原理,并聚焦其在合并高血压的慢性肾脏病患者中的未来应用前景。

要点

  • 假手术对照试验显示肾脏去神经术降压有效且安全性良好。
  • 慢性肾脏病患者心血管风险高且血压难以控制,去神经术可能适用。
  • 去神经术在慢性肾脏病高血压管理中的角色尚待进一步研究。

核心结论

  • 肾脏去神经术是降压新选择,对合并高血压的慢性肾脏病患者具有潜在应用价值。

研究设计与样本

  • 综述,基于近期系列假手术对照试验的证据,从肾内科视角进行讨论。

主要发现

  • 假手术对照试验报告肾脏去神经术具有显著降压疗效且耐受性和安全性非常良好。

临床怎么用

  • 肾内科医生应关注肾脏去神经术作为慢性肾脏病合并高血压患者的潜在降压手段。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Catheter-based renal denervation to reduce high blood pressure (BP) has received well-deserved attention after a recent series of sham-controlled trials reported significant antihypertensive efficacy and very favourable tolerability and safety of the intervention. This emerging treatment option is of high relevance to nephrologists. Patients with chronic kidney disease (CKD) are at elevated risk of cardiovascular adverse events and often present with hypertension, which is very difficult to control with medication. Renal denervation promises a new tool to reduce BP and to prevent loss of renal function in this population. The current review considers the role of the kidney and neurohormonal activation in the development of hypertension and the rationale for renal denervation. The current state of the evidence for the effectiveness and tolerability of the procedure is considered from the nephrologists' perspective, with a focus on the potential future role of renal denervation in the management of CKD patients with hypertension.

来源:Nephrol Dial Transplant,查看原文。版权归原作者所有。

引用

  1. Schmieder RE. Renal denervation: where do we stand and what is the relevance to the nephrologist? Nephrol Dial Transplant. 2022. PMID: 33200209. doi:10.1093/ndt/gfaa237

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。